0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-Acting Contraceptive Pills Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-8M18626
Home | Market Reports
Global Long Acting Contraceptive Pills Market Research Report 2024
BUY CHAPTERS

Global Long-Acting Contraceptive Pills Market Research Report 2026

Code: QYRE-Auto-8M18626
Report
2026-01-30
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Long-Acting Contraceptive Pills Market Size

The global Long-Acting Contraceptive Pills market was valued at US$ 87.51 million in 2025 and is anticipated to reach US$ 182 million by 2032, at a CAGR of 11.2% from 2026 to 2032.

Long-Acting Contraceptive Pills Market

Long-Acting Contraceptive Pills Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Long-Acting Contraceptive Pills competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Long-acting contraceptives are medications or devices that provide sustained contraceptive effects with a single or periodic use. These contraceptives include injectables, subdermal implants, and intrauterine devices (IUDs), which can prevent pregnancy for months to years. They are designed to offer reliable, long-term contraception without the need for daily administration, making them suitable for women seeking extended protection against pregnancy.
The North American market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Long-Acting Contraceptive Pills is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Long-Acting Contraceptive Pills include Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, Bayer, Merck, Sun Pharma, Shanghai Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Long-Acting Contraceptive Pills market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Long-Acting Contraceptive Pills. The Long-Acting Contraceptive Pills market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Long-Acting Contraceptive Pills market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Long-Acting Contraceptive Pills manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Long-Acting Contraceptive Pills Market Report

Report Metric Details
Report Name Long-Acting Contraceptive Pills Market
Accounted market size in 2025 US$ 87.51 million
Forecasted market size in 2032 US$ 182 million
CAGR 11.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Injectables
  • Subdermal Implants
  • Intrauterine Devices
  • Other
by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, Bayer, Merck, Sun Pharma, Shanghai Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Long-Acting Contraceptive Pills manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Long-Acting Contraceptive Pills sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Long-Acting Contraceptive Pills Market growing?

Ans: The Long-Acting Contraceptive Pills Market witnessing a CAGR of 11.2% during the forecast period 2026-2032.

What is the Long-Acting Contraceptive Pills Market size in 2032?

Ans: The Long-Acting Contraceptive Pills Market size in 2032 will be US$ 182 million.

Who are the main players in the Long-Acting Contraceptive Pills Market report?

Ans: The main players in the Long-Acting Contraceptive Pills Market are Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, Bayer, Merck, Sun Pharma, Shanghai Pharmaceuticals

What are the Application segmentation covered in the Long-Acting Contraceptive Pills Market report?

Ans: The Applications covered in the Long-Acting Contraceptive Pills Market report are Hospital, Clinic

What are the Type segmentation covered in the Long-Acting Contraceptive Pills Market report?

Ans: The Types covered in the Long-Acting Contraceptive Pills Market report are Injectables, Subdermal Implants, Intrauterine Devices, Other

1 Long-Acting Contraceptive Pills Market Overview
1.1 Product Definition
1.2 Long-Acting Contraceptive Pills by Type
1.2.1 Global Long-Acting Contraceptive Pills Market Value by Type: 2025 vs 2032
1.2.2 Injectables
1.2.3 Subdermal Implants
1.2.4 Intrauterine Devices
1.2.5 Other
1.3 Long-Acting Contraceptive Pills by Application
1.3.1 Global Long-Acting Contraceptive Pills Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Long-Acting Contraceptive Pills Market Size Estimates and Forecasts
1.4.1 Global Long-Acting Contraceptive Pills Revenue 2021–2032
1.4.2 Global Long-Acting Contraceptive Pills Sales 2021–2032
1.4.3 Global Long-Acting Contraceptive Pills Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Long-Acting Contraceptive Pills Market Competition by Manufacturers
2.1 Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021–2026)
2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Long-Acting Contraceptive Pills Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Types and Applications
2.7 Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Entry into the Industry
2.8 Global Long-Acting Contraceptive Pills Market Competitive Situation and Trends
2.8.1 Global Long-Acting Contraceptive Pills Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Long-Acting Contraceptive Pills Players Market Share by Revenue
2.8.3 Global Long-Acting Contraceptive Pills Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-Acting Contraceptive Pills Market Scenario by Region
3.1 Global Long-Acting Contraceptive Pills Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Long-Acting Contraceptive Pills Sales by Region: 2021–2032
3.2.1 Global Long-Acting Contraceptive Pills Sales by Region: 2021–2026
3.2.2 Global Long-Acting Contraceptive Pills Sales by Region: 2027–2032
3.3 Global Long-Acting Contraceptive Pills Revenue by Region: 2021–2032
3.3.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2021–2026
3.3.2 Global Long-Acting Contraceptive Pills Revenue by Region: 2027–2032
3.4 North America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.4.1 North America Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.4.3 North America Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.5.1 Europe Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.5.3 Europe Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-Acting Contraceptive Pills Market Facts & Figures by Region
3.6.1 Asia Pacific Long-Acting Contraceptive Pills Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Long-Acting Contraceptive Pills Sales by Region (2021–2032)
3.6.3 Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.7.1 Latin America Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.7.3 Latin America Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.8.3 Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-Acting Contraceptive Pills Sales by Type (2021–2032)
4.1.1 Global Long-Acting Contraceptive Pills Sales by Type (2021–2026)
4.1.2 Global Long-Acting Contraceptive Pills Sales by Type (2027–2032)
4.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021–2032)
4.2 Global Long-Acting Contraceptive Pills Revenue by Type (2021–2032)
4.2.1 Global Long-Acting Contraceptive Pills Revenue by Type (2021–2026)
4.2.2 Global Long-Acting Contraceptive Pills Revenue by Type (2027–2032)
4.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021–2032)
4.3 Global Long-Acting Contraceptive Pills Price by Type (2021–2032)
5 Segment by Application
5.1 Global Long-Acting Contraceptive Pills Sales by Application (2021–2032)
5.1.1 Global Long-Acting Contraceptive Pills Sales by Application (2021–2026)
5.1.2 Global Long-Acting Contraceptive Pills Sales by Application (2027–2032)
5.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021–2032)
5.2 Global Long-Acting Contraceptive Pills Revenue by Application (2021–2032)
5.2.1 Global Long-Acting Contraceptive Pills Revenue by Application (2021–2026)
5.2.2 Global Long-Acting Contraceptive Pills Revenue by Application (2027–2032)
5.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021–2032)
5.3 Global Long-Acting Contraceptive Pills Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zhejiang Xianju Pharmaceutical
6.1.1 Zhejiang Xianju Pharmaceutical Company Information
6.1.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.1.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Merck Long-Acting Contraceptive Pills Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Shanghai Pharmaceuticals
6.9.1 Shanghai Pharmaceuticals Company Information
6.9.2 Shanghai Pharmaceuticals Description and Business Overview
6.9.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.9.5 Shanghai Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-Acting Contraceptive Pills Industry Chain Analysis
7.2 Long-Acting Contraceptive Pills Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-Acting Contraceptive Pills Production Mode & Process Analysis
7.4 Long-Acting Contraceptive Pills Sales and Marketing
7.4.1 Long-Acting Contraceptive Pills Sales Channels
7.4.2 Long-Acting Contraceptive Pills Distributors
7.5 Long-Acting Contraceptive Pills Customer Analysis
8 Long-Acting Contraceptive Pills Market Dynamics
8.1 Long-Acting Contraceptive Pills Industry Trends
8.2 Long-Acting Contraceptive Pills Market Drivers
8.3 Long-Acting Contraceptive Pills Market Challenges
8.4 Long-Acting Contraceptive Pills Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Long-Acting Contraceptive Pills Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Long-Acting Contraceptive Pills Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Long-Acting Contraceptive Pills Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Long-Acting Contraceptive Pills Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Long-Acting Contraceptive Pills Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Types and Applications
 Table 12. Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-Acting Contraceptive Pills Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-Acting Contraceptive Pills Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Long-Acting Contraceptive Pills Sales by Region (K Units), 2021–2026
 Table 18. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021–2026)
 Table 19. Global Long-Acting Contraceptive Pills Sales by Region (K Units), 2027–2032
 Table 20. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2027–2032)
 Table 21. Global Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021–2026)
 Table 23. Global Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2027–2032)
 Table 25. North America Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
 Table 27. North America Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
 Table 28. North America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
 Table 32. Europe Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
 Table 33. Europe Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
 Table 42. Latin America Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
 Table 43. Latin America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2021–2026)
 Table 51. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2027–2032)
 Table 52. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021–2026)
 Table 53. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2027–2032)
 Table 54. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021–2026)
 Table 57. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2027–2032)
 Table 58. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2021–2026)
 Table 61. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2027–2032)
 Table 62. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021–2026)
 Table 63. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2027–2032)
 Table 64. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021–2026)
 Table 67. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2027–2032)
 Table 68. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2027–2032)
 Table 70. Zhejiang Xianju Pharmaceutical Company Information
 Table 71. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 72. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product
 Table 74. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Pfizer Long-Acting Contraceptive Pills Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Mylan Long-Acting Contraceptive Pills Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Teva Pharmaceuticals Company Information
 Table 86. Teva Pharmaceuticals Description and Business Overview
 Table 87. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product
 Table 89. Teva Pharmaceuticals Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Cipla Long-Acting Contraceptive Pills Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Bayer Company Information
 Table 96. Bayer Description and Business Overview
 Table 97. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Bayer Long-Acting Contraceptive Pills Product
 Table 99. Bayer Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Merck Long-Acting Contraceptive Pills Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Sun Pharma Company Information
 Table 106. Sun Pharma Description and Business Overview
 Table 107. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Sun Pharma Long-Acting Contraceptive Pills Product
 Table 109. Sun Pharma Recent Developments/Updates
 Table 110. Shanghai Pharmaceuticals Company Information
 Table 111. Shanghai Pharmaceuticals Description and Business Overview
 Table 112. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product
 Table 114. Shanghai Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Long-Acting Contraceptive Pills Distributors List
 Table 118. Long-Acting Contraceptive Pills Customers List
 Table 119. Long-Acting Contraceptive Pills Market Trends
 Table 120. Long-Acting Contraceptive Pills Market Drivers
 Table 121. Long-Acting Contraceptive Pills Market Challenges
 Table 122. Long-Acting Contraceptive Pills Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-Acting Contraceptive Pills
 Figure 2. Global Long-Acting Contraceptive Pills Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Long-Acting Contraceptive Pills Market Share by Type: 2025 & 2032
 Figure 4. Injectables Product Picture
 Figure 5. Subdermal Implants Product Picture
 Figure 6. Intrauterine Devices Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Long-Acting Contraceptive Pills Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Long-Acting Contraceptive Pills Market Share by Application: 2025 & 2032
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Global Long-Acting Contraceptive Pills Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Long-Acting Contraceptive Pills Market Size (US$ Million), 2021–2032
 Figure 14. Global Long-Acting Contraceptive Pills Sales (K Units), 2021–2032
 Figure 15. Global Long-Acting Contraceptive Pills Average Price (US$/Unit), 2021–2032
 Figure 16. Long-Acting Contraceptive Pills Report Years Considered
 Figure 17. Long-Acting Contraceptive Pills Sales Share by Manufacturers in 2025
 Figure 18. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Long-Acting Contraceptive Pills Players: Market Share by Revenue in Long-Acting Contraceptive Pills in 2025
 Figure 20. Long-Acting Contraceptive Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
 Figure 23. North America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
 Figure 24. United States Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
 Figure 27. Europe Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Long-Acting Contraceptive Pills Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Long-Acting Contraceptive Pills Revenue Market Share by Region (2021–2032)
 Figure 35. China Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Long-Acting Contraceptive Pills by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Long-Acting Contraceptive Pills by Type (2021–2032)
 Figure 55. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Long-Acting Contraceptive Pills by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Long-Acting Contraceptive Pills by Application (2021–2032)
 Figure 58. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2021–2032)
 Figure 59. Long-Acting Contraceptive Pills Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS